Bakewell John K
CIK 0001183553
Director
Filings
12
Latest May 19, 2026
Issuers covered
3
Showing
12 of 12
Page 1
Track record
2 of 2 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 2 | 100% | +28.0% | +28.0% | +31.3% | +24.8% |
| 90 days | 2 | 100% | +42.8% | +42.8% | +44.3% | +41.4% |
| 180 days | 2 | 100% | +64.5% | +64.5% | +77.6% | +51.4% |
| 365 days | 2 | 100% | +40.8% | +40.8% | +64.3% | +17.3% |
Issuers
Companies where Bakewell John K has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| TMCI | Treace Medical Concepts, Inc. | 6 | May 19, 2026 |
| XTNT | Xtant Medical Holdings, Inc. | 4 | Nov 18, 2025 |
| STIM | Neuronetics, Inc. | 2 | May 26, 2023 |
All filings
12 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|